Lifestyle advice for people with adenomas after a positive colorectal screening test
Official title: Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)
Run by Centre Leon Berard · NCT06827366 · Data updated 2026-11-12
This trial will try giving evidence-based diet and lifestyle advice to people in France who had a positive FIT and adenomas but no cancer to see if it improves their diet, activity, quality of life, and body measurements over one year.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 74 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Centre Leon Berard Academic / other |
| Locations | 1 site (Lyon, France) |
| Status | Recruiting |
| Started | January 26, 2026 |
| Main results expected | November 15, 2027 |
| Study ends | February 15, 2028 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT06827366 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are French-speaking adults in the Rhône region who had a positive FIT, were found to have adenomas but no colorectal cancer at colonoscopy, can commit to one year of follow-up, and have baseline adherence ≤7/9 to the recommendations.
✕Probably not a fit
Patients on strict medical diets, with severe mobility limitations, with chronic inflammatory bowel disease or prior colorectal cancer, pregnant people, or those unable to follow the intervention materials are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a two-arm randomized controlled trial comparing an evidence-based diet and lifestyle advice program with usual care for individuals at higher colorectal cancer risk identified through screening. Participants are recruited after a positive fecal immunochemical test (FIT) and colonoscopy showing adenomas but no cancer, and the intervention is delivered by health professionals using leaflets, posters and digital materials based on WCRF and French INCA recommendations and habit-formation theory. Primary outcomes include adherence to target diet and lifestyle recommendations, subjective health measures including quality of life, and anthropometric changes; biospecimen collection was removed after a 2022–2024 pilot for feasibility reasons. Enrollment and follow-up last one year, with random allocation to intervention or usual care.
Why it matters
Potential benefit: If successful, participants may improve their diet and physical activity, reduce weight or waist size, and potentially lower future colorectal cancer risk.
How similar studies have gone: Previous lifestyle-advice interventions have shown moderate success at improving diet and physical activity in prevention settings, but delivering structured advice at the point of colorectal screening is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having read the information note and agreeing to participate * Will and availability to be committed for a full year * At high risk for CRC but CRC negative * Affiliated to a health security system * Having a score on the adherence to the recommendation lower than or equal to 7 out of 9 at baseline. * Able to read, write and understand French Exclusion Criteria: * Under a strict diet such as meal replacements, diets for co-morbidities such as diabetes * Immobile due to physical constraints (e.g. handicap that is not compatible with physical activities) * Extensive intestinal surgery such as colectomy or surgical resection of the colon * Chronic gastrointestinal illness (IBD, IBS, celiac disease) * Colorectal cancer confirmed or history of a primary cancer * Severe malnutrition * Pregnant * Participation in another lifestyle study NB : For this study, there is no exclusion period from other research, and participants can simultaneously take part in another study unless it concerns lifestyle.
Where it's running
-
Centre Léon Bérard
Lyon, France, France Recruiting
Study contacts
- Study coordinator: Inge Huybretchts, PhD
- Email: huybrechtsi@iarc.who.int
- Phone: +33695925958
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Total underwater colonoscopy for better colorectal cancer screening
This study is testing if total underwater colonoscopy can find more hard-to-detect lesions during colorectal cancer screening in people who need a colonoscopy after a positive stool test.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.